Article

Transcriptomics based prediction of survival and response to therapy in malignant mesothelioma

2022-04-14

Abstract excerpt

<h4>ABSTRACT</h4> Malignant mesothelioma is an aggressive cancer with limited treatment options and poor prognosis. Better understanding of mesothelioma genomics and transcriptomics could advance novel therapies. We performed whole-exome and RNA-sequencing of germline and tumors of 122 patients with pleural, peritoneal, and tunica-vaginalis mesothelioma. We identify a 48 gene prognostic signature that is highly p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9f0b73f2-0fc5-517b-9396-2c2f40e76927
DOI: 10.1101/2022.04.13.488207

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Transcriptomics based prediction of survival and response to therapy in malignant mesotheliomaDOI 10.1101/2022.04.13.488207Read

Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesotheliomaSemantic proximity Read

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesotheliomaSemantic proximity Read

Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome SequencingSemantic proximity Read

Recent Insights Emerging from Malignant Mesothelioma Genome SequencingSemantic proximity Read

Redefining mesothelioma types as a continuum uncovers the immune and vascular systems as key players in the diagnosis and prognosis of this diseaseSemantic proximity Read

Genomic Landscape of Malignant Mesotheliomas.Semantic proximity Read

BAP1 Loss Predicts Therapeutic Vulnerability in Malignant Peritoneal MesotheliomaSemantic proximity Read

Application of a Neural Network Whole Transcriptome–Based Pan-Cancer Method for Diagnosis of Primary and Metastatic CancersSemantic proximity Read

Genomics and Epigenetics of Malignant MesotheliomaSemantic proximity Read

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.Semantic proximity Read

Integrated genomics identify novel immunotherapy targets for malignant mesotheliomaSemantic proximity Read

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesotheliomaSemantic proximity Read